Serum biomarkers identify critically ill traumatic brain injury patients for MRI.

ABSTRACT:

Background

Magnetic resonance imaging (MRI) carries prognostic importance after traumatic brain injury (TBI), especially when computed tomography (CT) fails to fully explain the level of unconsciousness. However, in critically ill patients, the risk of deterioration during transfer needs to be balanced against the benefit of detecting prognostically relevant information on MRI. We therefore aimed to assess if day of injury serum protein biomarkers could identify critically ill TBI patients in whom the risks of transfer are compensated by the likelihood of detecting management-altering neuroimaging findings.

Methods

Data were obtained from the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study. Eligibility criteria included:

SUBMITTER: Richter S 

PROVIDER: S-EPMC9706877 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature